Topics - APIs
Refine By
Content Type
FeaturesBreaking News
Columns
Editorial
Online Exclusives
Industry News
Industry Events
Buyers Guide Companies
Business Corner
Expert's Opinion
White Papers / Tech Papers
Classifieds
Services
Product Releases
Case Studies
Top Companies Report
Jobs
Videos
Collaborations & Alliances
Promotions & Movies
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
Advanced Degrees
Financial Analysis
I Mak
Lowe Down
Managing Your Careeer
Pharma Beat
Preclinical Outsourcing
Salary Survey
Outsourcing Survey
Contracting & Outsourcing
Literature / Brochures
CRO News
FDA Watch
India Report
Executive Perspective
Ask The Board
Glossary
Posters
News Releases
Provider Survey
Conference Sessions
Ask The Experts
Published May 3, 2013
Expands market capabilities to include pharmaceutical use for Niacin Read More »
Published April 18, 2013
Expands global supply chain to support Vascepa Read More »
Published March 12, 2013
APIC gains dedicated capacity for client needs Read More »
By Andrew Badrot, CMS Pharma
Published March 6, 2013
Can Teva’s new model change pharma’s fortunes? Read More »
Published March 5, 2013
Will provide scale-up, process validation, and commercial scale supply Read More »
Published March 5, 2013
Adds capabilities for solid dispersions and oral solid dosages Read More »
Published March 5, 2013
Adds Dry Powder Manufacturing Capabilities Read More »
Published February 21, 2013
Aims to develop excipients to enhance solubility, bioavailability Read More »
Published February 20, 2013
Aims to provide new processes for API development and manufacture Read More »
Published February 19, 2013
Offers microencapsulation technology for API scale up Read More »
Published February 19, 2013
Provides access to enzyme technologies and services for API manufacture Read More »
Published February 14, 2013
Aims to identify and commercialize new technologies Read More »
Published February 13, 2013
Aims to improve manufacturing routes for selected APIs Read More »
Published February 7, 2013
Revenues up 7% in the quarter Read More »
By Gil Y. Roth, Contract Pharma
Published January 22, 2013
A preview of our upcoming GDUFA & CMOs article Read More »
